FDA Inspection 1300468 - Safrel Pharmaceuticals LLC - January 30, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Safrel Pharmaceuticals LLC, with an inspection on January 30, 2026, issued by the New Jersey District Office, covering human drugs.

Company: Safrel Pharmaceuticals LLC
Inspection Date: January 30, 2026
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 736c7b2a-37b0-4e12-a24c-937b15b480ed

Violation Codes10

21 CFR 111.10321 CFR 111.455(a)21 CFR 111.475(b)21 CFR 111.535(b)21 CFR 111.55321 CFR 211.100(a)21 CFR 211.150(b)21 CFR 211.180(c)21 CFR 211.22(a)21 CFR 211.42(a)

Full citation text and observation details available on the Dashboard.